HTX

Veredus Laboratories’ VereCoV detection kit obtains provisional approval for IVD use
By Dean Koh | 02:12 am | March 03, 2020
With the authorization by HSA, the VereCoV Detection Kit can be used directly by laboratories or hospitals to test patients for clinical diagnosis as an in-vitro diagnostic product (IVD).